Insights into ancestral diversity in Parkinson’s disease risk: a comparative assessment of polygenic risk scores.

Publication date: Jul 03, 2025

Risk prediction models play a crucial role in advancing healthcare by enabling early detection and supporting personalized medicine. Nonetheless, polygenic risk scores (PRS) for Parkinson’s disease (PD) have not been extensively studied across diverse populations, contributing to health disparities. In this study, we constructed 105 PRS using individual-level data from seven ancestries and compared two different models. Model 1 was based on the cumulative effect of 90 known European PD risk variants, weighted by summary statistics from four independent ancestries (European, East Asian, Latino/Admixed American, and African/Admixed). Model 2 leveraged multi-ancestry summary statistics using a p-value thresholding approach to improve prediction across diverse populations. Our findings provide a comprehensive assessment of PRS performance across ancestries and highlight the limitations of a “one-size-fits-all” approach to genetic risk prediction. We observed variability in predictive performance between models, underscoring the need for larger sample sizes and ancestry-specific approaches to enhance accuracy. These results establish a foundation for future research aimed at improving generalizability in genetic risk prediction for PD.

Open Access PDF

Concepts Keywords
Asian Admixed
Future Ancestries
Genetic Assessment
Latino Diverse
Medicine European
Models
Parkinson
Pd
Polygenic
Populations
Prs
Risk
Scores
Statistics
Summary

Semantics

Type Source Name
disease MESH Parkinson’s disease
disease MESH polygenic risk scores
disease MESH health disparities
drug DRUGBANK Coenzyme M
drug DRUGBANK Saquinavir
disease MESH tics
drug DRUGBANK Tropicamide
disease MESH Movement Disorder
drug DRUGBANK Ademetionine
disease MESH privacy
drug DRUGBANK Sulpiride
disease MESH Parkinsonism
disease MESH neurological disorders
pathway KEGG Parkinson disease
disease MESH Stroke
drug DRUGBANK (S)-Des-Me-Ampa
pathway REACTOME Reproduction
disease MESH Dementias
disease MESH Neurodegenerative Diseases
pathway REACTOME Neurodegenerative Diseases
drug DRUGBANK Pirenzepine
drug DRUGBANK Troleandomycin
drug DRUGBANK Ribostamycin

Original Article

(Visited 3 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *